{%youtube%}dQw4w9WgXcQ{%endyoutube%}

{% reveal text="Click here to reveal my secret" %}Your element to **hide**{% endreveal %}

# Approach (a systematic approach is vital)

1. Rate (是否有 tachy or brady) and rhythm (是否有 P waves, regularity, P & QRS relationship)
2. Intervals (PR, QRS, QT) and axis (是否有 LAD or RAD)
3. Chamber 異常 (是否有 LAA and/or RAA, 是否有 LVH and/or RVH)
4. QRST changes (是否有 Q waves, poor R-wave progression V 1 –V 6 , ST ↑/↓ or T-wave ∆s)

## Left axis deviation (LAD)

1.  定義: axis beyond –30° (S > R in lead II)
2.  Etiologies: LVH, LBBB, inferior MI, WPW
3.  Left anterior fascicular block (LAFB): LAD (–45 to –90°) and qR in aVL and QRS <120 msec and no other cause of LAD (eg, IMI)

## Right axis deviation (RAD) 

1. 定義: 
   - axis beyond +90° (S > R in lead I)
2. 原因: 
   - RVH, PE, COPD (usually not > +110°), septal defects, lateral MI, WPW
3. Left posterior fascicular block (LPFB): 
   - RAD (90–180°) and rS in I & aVL and qR in III & aVF and QRS <120 msec and no other cause of RAD

Bifascicular block: RBBB + LAFB/LPFB. “Trifascicular block”: bifascicular block + 1° AVB.

Prolonged QT interval (NEJM 2008;358:169; www.torsades.org)

• Measure QT from start of QRS to end of Tw (use longest QT, often V2-V3, omit U wave)

• QT varies w/ HR → corrected w/ Bazett formula: QTc = QT/ (RR in sec), overcorrects at high HR, undercorrects at low HR (nl QTc <450 msec ♂, <460 msec ♀)

• Fridericia’s formula preferred at very high or low HR: QTc = QT/

• QT prolongation a/w ↑ risk TdP (espec >500 msec); establish baseline QT and monitor if using QT prolonging meds, no estab guidelines for stopping Rx if QT prolongs

• Etiologies:

Antiarrhythmics: class Ia (procainamide, disopyramide), class III (amio, sotalol, dofet) Psych drugs: antipsychotics (phenothiazines, haloperidol, atypicals), Li, ? SSRI, TCA Antimicrobials: macrolides, quinolones, azoles, pentamidine, atazanavir

18 Other: antiemetics (droperidol, 5-HT 3 antagonists), alfuzosin, methadone, ranolazine Electrolyte disturbances: hypoCa (nb, hyperCa a/w ↓ QT), ±

hypoK, ? hypoMg Autonomic dysfxn: ICH (deep TWI), Takotsubo, stroke,

CEA, neck dissection Congenital (long QT syndrome): K, Na, & Ca

channelopathies (Circ 2013;127:126) Misc: CAD, CMP, bradycardia, high-grade AVB,

hypothyroidism, hypothermia, BBB

Left ventricular hypertrophy (LVH) (Circ 2009;119:e251)

• Etiologies: HTN, AS/AI, HCM, coarctation of aorta

• Criteria (all w/ Se <50%, Sp >85%; accuracy affected by age, sex, race, BMI) Sokolow-Lyon: S in V 1 + R in V 5 or V 6 ≥35 mm or R in aVL

≥11 mm (↓ Se w/ ↑ BMI) Cornell: R in aVL + S in V

3

>28 mm in men or >20 mm in

women Romhilt-Estes point-score system (4 points = probable; 5 points = diagnostic): ↑ volt: limb lead R or S ≥20 mm or S in V 1 or V 2 ≥30 mm or R in V 5 or V 6 ≥30 mm (3 pts)

ST displacement opposite to QRS deflection: w/o dig (3 pts); w/ dig (1 pt) LAA (3 pts); LAD (2 pts); QRS duration ≥90 msec (1 pt) Intrinsicoid deflection (QRS onset to peak of R) in V 5 or V 6

≥50 msec (1 pt) If LAFB present: S in III + max (R+S) in any lead ≥30 mm in men or ≥28 mm in women

Right ventricular hypertrophy (RVH) (Circ 2009;119:e251; JACC 2014;63:672) • Etiologies: cor pulmonale, congenital (tetralogy of Fallot, TGA, PS, ASD, VSD), MS, TR

19 • Criteria [all insensitive, but specific (except in COPD); all w/ poor PPV in general population] R > S in V 1 , R in V 1 ≥6 mm, S in V 5 ≥10 mm, S in V 6 ≥3 mm,

R in aVR ≥4 mm RAD ≥110° (LVH + RAD or prominent S in V

5

or V 6 →

consider biventricular hypertrophy)

Ddx of dominant R wave in V 1 or V 2

• Ventricular abnl: RVH (RAD, RAA, deep S waves in I, V 5 , V 6 );

HCM; Duchenne’s

• Myocardial injury: posterior MI (anterior R wave = posterior Q wave; often with IMI)

• Abnormal depolarization: RBBB (QRS >120 msec, rSR′); WPW (↓ PR, δ wave, ↑ QRS)

• Other: dextroversion; counterclockwise rotation; lead misplacement; nl variant

Poor R wave progression (PRWP) (Am Heart J 2004;148:80)

• Definition: loss of anterior forces w/o frank Q waves (V 1 –V 3 ); R

wave in V 3 ≤3 mm

• Possible etiologies (nonspecific):

old anteroseptal MI (usually w/ R wave V

3

≤1.5 mm, ±

persistent ST ↑ or TWI V 2 & V 3 )

LVH (delayed RWP w/ ↑ left precordial voltage), RVH, COPD (may also have RAA, RAD, limb lead QRS amplitude ≤5 mm, S I S II S III w/ R/S ratio <1 in those leads)

LBBB; WPW; clockwise misplacement; CMP; PTX

rotation

of

the

heart;

lead

Pathologic Q waves

• Definition: ≥30 msec (≥20 msec V 2 –V 3 ) or >25% height of R

wave in that QRS complex • Small (septal) q waves in I, aVL, V

5

& V 6 are nl, as can be

isolated Qw in III, aVR, V

1

• “Pseudoinfarct” pattern may be seen in LBBB, infiltrative dis., HCM, COPD, PTX, WPW

ST elevation (STE) (NEJM 2003;349:2128; Circ 2009;119:e241 & e262)

• Acute MI: upward convexity STE (ie, a “frown”) ± TWI (or prior MI w/ persistent STE)

20 • Coronary spasm: Prinzmetal’s angina; transient STE in a coronary distribution

• Pericarditis: diffuse, upward concavity STE (ie, a “smile”); a/w PR ↓; Tw usually upright

• HCM, Takotsubo CMP, ventricular aneurysm, cardiac contusion

• Pulmonary embolism: occ. STE V 1 –V 3 ; classically a/w TWI V 1 –

V 4 , RAD, RBBB, S 1 Q 3 T 3

• Repolarization abnormalities:

LBBB (↑ QRS duration, STE discordant from QRS complex; see “ACS” for dx MI in LBBB) LVH (↑ QRS amplitude); Brugada syndrome (rSR′, downsloping STE V 1 –V 2 ); pacing

Hyperkalemia (↑ QRS duration, tall Ts, no P’s); epsilon waves (late afterdepol.) in ARVC • aVR: STE >1 mm a/w ↑ mortality in STEMI; STE aVR > V 1 a/w

left main disease • Early repolarization: most often seen in V 2 –V 5 in young adults

(Circ 2016;133:1520)

1–4 mm elev of peak of notch or start of slurred downstroke of R wave (ie, J point); ± up concavity of ST & large Tw (ħ ratio of STE/T wave <25%; may disappear w/ exercise) ? early repol in inf leads may be a/w ↑ risk of VF (NEJM

2009;361:2529; Circ 2011;124:2208)

ST depression (STD)

• Myocardial ischemia (± Tw abnl)

• Acute true posterior MI: posterior STE appearing as anterior STD (± ↑ R wave) in V 1 –V 3 俶 posterior ECG leads; manage

as a STEMI with rapid reperfusion (see “ACS”)

• Digitalis effect (downsloping ST ± Tw abnl; does not correlate w/ dig levels)

• Hypokalemia (± U wave)

• Repolarization abnl a/w LBBB or LVH (usually in leads V 5 , V 6 , I,

aVL)

T wave inversion (TWI; generally ≥1 mm; deep if ≥5 mm) (Circ

2009;119:e241)

• Ischemia or infarct; Wellens’ sign (deep, symm precordial TWI) → critical prox LAD lesion

21 • Myopericarditis; CMP (Takotsubo, ARVC, apical HCM); MVP; PE (espec if TWI V 1 –V 4 )

• Repolarization abnl in a/w LVH/RVH (“strain pattern”); BBB; nl variant if QRS predom. 䶀

• Posttachycardia or postpacing (“memory” T waves)

• Electrolyte, digoxin, PaO 2 , PaCO 2 , pH/core temp ∆’s, intracranial

bleed (“cerebral Tw”)

Low voltage

• QRS amplitude (R + S) <5 mm in all limb leads & <10 mm in all precordial leads

• Etiol: COPD, pericard./pleural effusion, myxedema, ↑ BMI, amyloid, diffuse CAD

Electrolyte abnormalities

• ↑ K: tented Tw, ↓ QT, ↑ PR, AVB, wide QRS, STE; ↓ K: flattened Tw, U waves, ↑ QT

• ↑ Ca: ↓ QT, flattened Tw & Pw, J point elevation; ↓ Ca: ↑ QT; Tw ∆s

ECG in young athletes (JACC 2017;69:805)

• Normal patterns may incl. LVH, RVH, early repol

• Evaluate if: arrhythmias, HR <30, prolonged QT, ε/δ waves, LBBB, Brugada pattern, QRS >140 ms, PR >400 ms, Mobitz II, 3˚ AVB, ST depression, TWI